-
Targeting ANXA4 to Overcome Cisplatin Resistance in Ovarian Cancer: A Bioinformatics and in Vitro Study
06 Nov 2025 14:09 GMT
… ovarian, gastric, and lung cancers, ANXA4 has been found … of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer … cisplatin resistance of lung cancer cells via promoting … chemoresistance to paclitaxel in lung cancer cells. Oncotarget. 2016 …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… pCR and MPR.
About Lung Cancer
Lung cancer is the leading cause … been previously treated with sorafenib.
OPDIVO® (nivolumab) … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial
02 Apr 2025 23:47 GMT
… patients with advanced squamous lung cancer, according to a press … at the 2025 European Lung Cancer Congress (ELCC). The trial … Center consistently shows that lung cancer has the highest incidence … 15.2 months with sorafenib. Median progression-free survival …
-
Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity
17 Jul 2025 18:58 GMT
… without any further purification. Sorafenib (Ark Pharma Scientific, … -mediated ASGPR targeting. Sorafenib, released from hepatocytes, … Phosphate buffer solution; Sor, Sorafenib; STING, Stimulator of … gefitinib resistance in lung cancer by activating ERBB3 …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading cause … been previously treated with sorafenib. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … been previously treated with sorafenib. This indication is … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … Raez LE. Efficacy of sorafenib, a multi-tyrosine kinase … -L1 expression in rare lung tumors. Pathol Oncol Res. …
-
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative Review
30 Oct 2025 23:59 GMT
… immune microenvironment in lung cancer, demonstrating the potential … plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma … immunotherapy response in lung cancer patients. Semin Nucl … non-small cell lung cancer: a retrospective multicohort …
-
<![CDATA[Avoiding Surgical Resection of Recurrent BRAF V600E–Mutated Iodine-Refractory Papillary Thyroid Cancer Involving Trachea/Thyroid Cartilage via Resensitization With Dabrafenib and Trametinib: Report of 3 Cases]]>
30 Oct 2025 19:26 GMT
… inhibitors mainly targeting VEGFR (ie, sorafenib [Nexavar], lenvatinib Lenvima], cabozantinib [Cabometyx]) are … treat melanoma, non–small cell lung cancer, and anaplastic thyroid cancer harboring …
-
Nanomaterial-Driven Regulated Cell Death: Mechanistic Insights and Novel Strategies for Tumor Therapy
30 Oct 2025 11:46 GMT
… In non-small cell lung cancer, GSDMD downregulation inhibited … nano-modulator induces lung cancer ferroptosis and elicits … al. HSP90α mediates sorafenib resistance in human hepatocellular … synergizes with immunotherapy in lung cancer. Sig Transduct Target …
About
© 1995-2025